Inventor · disambiguated record
Steven John Woodhead
Also filed as: WOODHEAD STEVEN · WOODHEAD STEVEN J · WOODHEAD STEVEN JOHN
22 granted patents·16 pending applications·295 citations·filing 2003–2022
96Inventor score
Top patents by PatentIndex Score
38 records- 0195US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0295US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0394US9303029B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Apr 5, 2016·25 cites·20 claims
- 0494US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0594US8685980B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT EBAI·Filed 2009·Granted Apr 1, 2014·81 cites·15 claims
- 0693US9856236B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2015·Granted Jan 2, 2018·16 cites·20 claims
- 0793US9439896B2Quinolines as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Sep 13, 2016·22 cites·20 claims
- 0893US9290478B2Substituted quinoxalines as FGFR kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Mar 22, 2016·25 cites·20 claims
- 0992US10052320B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 21, 2018·11 cites·20 claims
- 1092US10039759B2Quinolines as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 7, 2018·11 cites·21 claims
- 1190US10519137B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2017·Granted Dec 31, 2019·6 cites·18 claims
- 1284US9416136B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT·Filed 2014·Granted Aug 16, 2016·8 cites·23 claims
- 1382US2024043428A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1480US8546407B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsBERDINI VALERIO·Filed 2005·Granted Oct 1, 2013·4 cites·18 claims
- 1577US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1676US9006430B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as proteinASTEX THERAPEUTICS LTD·Filed 2014·Granted Apr 14, 2015·2 cites·20 claims
- 1776US8691806B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 1876US8497294B2Compositions comprising (S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinasesWOODHEAD STEVEN JOHN·Filed 2011·Granted Jul 30, 2013·7 cites·8 claims
- 1975US8809336B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Granted Aug 19, 2014·2 cites·13 claims
- 2073US8796244B2Imidazopyridine derivatives as inhibitors of receptor tyrosine kinasesBERDINI VALERIO·Filed 2009·Granted Aug 5, 2014·2 cites·21 claims
- 2173US8247576B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2004·Granted Aug 21, 2012·5 cites·8 claims
- 2273US2021253578A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2368US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2464US2018155351A1Pyrrolopyrimidine compounds and their usesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2562US9283226B2Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 15, 2016·0 cites·20 claims
- 2656US2017183352A1Pyrrolopyrimidine compounds and their usesBESONG GILBERT·Filed 2016·Application pending·0 cites
- 2754US2010113551A1Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinasesASTEX THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 2853US2016250187A1Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 2947US2010093748A1Substituted piperidines having protein kinase inhibiting activityASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3046US2010120798A1Substituted piperidines containing a heteroarylamide or heteroarylphenyl moietyASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3145US2007082898A15 Amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseasesASTEX THERAPEUTICS LTD·Filed 2004·Application pending·0 cites
- 3245US2010016340A1Pharmaceutical compoundsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3343US2010210617A1Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase InhibitorsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3442US2008275029A1Compounds for Treating Protein-Kinase Mediated DisordersASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3542US2006063782A13-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitorsMURRAY CHRISTOPHER W·Filed 2003·Application pending·0 cites
- 3641US2009099213A1Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases InhibitorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3734US9598424B2Heteroarylamide inhibitors of TBK1TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Mar 21, 2017·0 cites·15 claims
- 3833US9994547B2Heteroarylamide inhibitors of TBK1TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 12, 2018·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Steven John Woodhead files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →